RTI Surgical announced it is launching two new bone grafting solutions at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans — NanOss Bioactive 3D and map3 Cellular Allogeneic Bone Graft.
NanOss Bioactive 3D is a synthetic 3D bioscaffold which supports bone formation, and map3 Cellular Allogeneic Bone Graft is an implant that contains the elements needed to generate and maintain new bone. It is a natural alternative to autograft.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws